http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2231043-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf57b059724b9bb8cec50b5fa96f04e7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9746257ae0371e4b951b4c1348b5f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7864db6709252f5108e1c7b5b64f3b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd1c7ef450f55738e6522c820ce13009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8d4aadc98b71f829dec9629ddaedf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9870f71fb796c9c31c5cc524530fb5e
publicationDate 2005-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2231043-A1
titleOfInvention PHARMACEUTICAL COMPOSITION OF EBASTINE FOR IMMEDIATE RELEASE AND ITS MANUFACTURING PROCESS.
abstract Pharmaceutical composition of SebastiannImmediate release and its manufacturing process.n n n The general body of the pharmaceutical compositionnit is constituted by a solution of non-micronized ebastine thatnCoats a pharmaceutically acceptable excipient with functionsnbinders, diluents and / or disintegrants. The solvent is anorganic solvent, preferably acetone; Meanwhile henExcipient is preferably microcrystalline cellulose. In whatn regarding the process starts from a first phase of granulation innwet track; followed by a second phase of fluid bed drying;na third phase of mixing; a fourth compression phase and anfifth phase of final coating.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012076919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617751-B2
priorityDate 2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03103713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0411629-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5997905-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6149943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0134124-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415887923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095

Total number of triples: 40.